Vimarsana
Biggest News Aggregation in the World

Page 3 - Recurrent Stroke News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Recurrent Stroke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Recurrent Stroke Today - Breaking & Trending Today

DOAC or VKA for Elderly Patients With Recent Stroke and AF? - Vimarsana News

DOAC or VKA for Elderly Patients With Recent Stroke and AF?

Until recently, clinicians had little evidence to guide their decisions about the most effective and safe treatment for the oldest patients with atrial fibrillation and recent stroke.

Earlier Anticoagulation Better After Ischemic Stroke in AF? - Vimarsana News

Earlier Anticoagulation Better After Ischemic Stroke in AF?

The observational ATTUNE study suggests that starting anticoagulation within 4 days of stroke leads to fewer new infarcts detected by imaging without an increase in hemorrhage compared with starting later.

Intraplaque hemorrhage in carotid stenosis doubles risk of recurrent stroke or TIA: Study - Vimarsana News

Intraplaque hemorrhage in carotid stenosis doubles risk of recurrent stroke or TIA: Study

Netherlands: In patients with mild-to-moderate carotid stenosis, carotid intraplaque hemorrhage (IPH) and total plaque volume increase the risk of transient ischemic attack or recurrent ipsilateral...

AXIOMATIC-SSP: Cautious Optimism on Factor XI Inhibitor in Stroke - Vimarsana News

AXIOMATIC-SSP: Cautious Optimism on Factor XI Inhibitor in Stroke

The new factor XI inhibitor antithrombotic, milvexian, showed promising results in a dose-finding phase 2 trial in patients with acute ischemic stroke or TIA, on top of dual antiplatelet therapy.

Social Isolation, Loneliness Tied to Death, MI, Stroke: AHA - Vimarsana News

Social Isolation, Loneliness Tied to Death, MI, Stroke: AHA

More than 4 decades of research has clearly demonstrated that social isolation and loneliness carry cardiovascular risks, a new American Heart Association scientific statement concludes.